Sexual Functioning in Endometrial Cancer

November 15, 2019 updated by: University of Wisconsin, Madison

Sexual Functioning in Endometrial Cancer Survivors

The purpose of this study is estimate how sexual function in endometrial cancer survivors varies with severity of disease.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

73

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Wisconsin
      • Madison, Wisconsin, United States, 53792
        • University of Wisconsin School of Medicine and Public Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

University of Wisconsin Gynecologic Oncology and Radiation Oncology Clinics

Description

Inclusion Criteria:

  • History of Stage I-IIIA endometrial adenocarcinoma of any grade
  • 1-5 years out from primary surgical treatment
  • Adjuvant therapy may only have consisted of radiation or hormonal therapy
  • No evidence of disease

Exclusion Criteria:

  • Previous treatment for other malignancies
  • Did not undergo surgery for primary treatment of endometrial cancer
  • Inability to read, write and speak fluent English
  • Major cognitive impairment affecting ability to provide consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Female Sexual Function Index (FSFI).
Time Frame: at time of enrollment
at time of enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Wisconsin, Madison

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2007

Primary Completion (Actual)

June 1, 2009

Study Completion (Actual)

June 1, 2009

Study Registration Dates

First Submitted

October 10, 2007

First Submitted That Met QC Criteria

October 10, 2007

First Posted (Estimate)

October 12, 2007

Study Record Updates

Last Update Posted (Actual)

November 19, 2019

Last Update Submitted That Met QC Criteria

November 15, 2019

Last Verified

September 1, 2009

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CC07703
  • A532820 (Other Identifier: UW Madison)
  • SMPH/OBSTET & GYNECOL (Other Identifier: UW Madison)
  • H-2007-0204 (Other Identifier: Institutional Review Board)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe